Announcements Trials

Browse Landscape

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1

Interventions

Gemcitabine 14 Cisplatin 13 Capecitabine 11 Paclitaxel 9 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 9 pembrolizumab 7 Albumin-Bound Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Nivolumab 5 Irinotecan 5 Docetaxel 5 Pemetrexed 4 Everolimus 4 Erlotinib Hydrochloride 4 Cyclophosphamide 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 trifluridine tipiracil drug combination 2 regorafenib 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × balstilimab × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡